610 related articles for article (PubMed ID: 16492667)
1. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667
[TBL] [Abstract][Full Text] [Related]
2. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
3. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation.
Rey A; Manen D; Rizzoli R; Caverzasio J; Ferrari SL
J Biol Chem; 2006 Dec; 281(50):38181-8. PubMed ID: 17038311
[TBL] [Abstract][Full Text] [Related]
4. Beta-arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type 1 receptor internalization.
Sneddon WB; Friedman PA
Endocrinology; 2007 Aug; 148(8):4073-9. PubMed ID: 17525124
[TBL] [Abstract][Full Text] [Related]
5. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
Yang Y; Wang B
Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
[TBL] [Abstract][Full Text] [Related]
6. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
7. Bombyx adipokinetic hormone receptor activates extracellular signal-regulated kinase 1 and 2 via G protein-dependent PKA and PKC but β-arrestin-independent pathways.
Huang H; He X; Deng X; Li G; Ying G; Sun Y; Shi L; Benovic JL; Zhou N
Biochemistry; 2010 Dec; 49(51):10862-72. PubMed ID: 21126059
[TBL] [Abstract][Full Text] [Related]
8. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling.
Syme CA; Friedman PA; Bisello A
J Biol Chem; 2005 Mar; 280(12):11281-8. PubMed ID: 15611080
[TBL] [Abstract][Full Text] [Related]
10. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ
Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells.
Quoyer J; Longuet C; Broca C; Linck N; Costes S; Varin E; Bockaert J; Bertrand G; Dalle S
J Biol Chem; 2010 Jan; 285(3):1989-2002. PubMed ID: 19915011
[TBL] [Abstract][Full Text] [Related]
12. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.
Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM
J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114
[TBL] [Abstract][Full Text] [Related]
13. Differential conformational requirements for activation of G proteins and the regulatory proteins arrestin and G protein-coupled receptor kinase in the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein.
Vilardaga JP; Frank M; Krasel C; Dees C; Nissenson RA; Lohse MJ
J Biol Chem; 2001 Sep; 276(36):33435-43. PubMed ID: 11387315
[TBL] [Abstract][Full Text] [Related]
14. Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Shenoy SK; Karnik SS; Hunyady L; Luttrell LM; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10782-7. PubMed ID: 12949261
[TBL] [Abstract][Full Text] [Related]
15. Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor.
Ren XR; Reiter E; Ahn S; Kim J; Chen W; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1448-53. PubMed ID: 15671180
[TBL] [Abstract][Full Text] [Related]
16. Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells.
Sneddon WB; Yang Y; Ba J; Harinstein LM; Friedman PA
Am J Physiol Renal Physiol; 2007 Mar; 292(3):F1028-34. PubMed ID: 17107942
[TBL] [Abstract][Full Text] [Related]
17. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
18. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2.
Zhao M; Wimmer A; Trieu K; Discipio RG; Schraufstatter IU
J Biol Chem; 2004 Nov; 279(47):49259-67. PubMed ID: 15364949
[TBL] [Abstract][Full Text] [Related]
19. The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling.
Charest PG; Oligny-Longpré G; Bonin H; Azzi M; Bouvier M
Cell Signal; 2007 Jan; 19(1):32-41. PubMed ID: 16857342
[TBL] [Abstract][Full Text] [Related]
20. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
